Systemic inhibition of interleukin (IL)-1 with rilonacept (IL-1 Trap) could be an effective therapy for the pain and inflammation associated with acute gout. As demonstrated in a novel mouse model ...

In a surprising development, however, Shaftel et al. have demonstrated in a mouse model of AD that long-term IL-1β overexpression leads to a reduction in amyloid pathology.